Results 121 to 130 of about 451,760 (295)

Cutaneous lymphoma : diagnosis and treatment

open access: yes
Drs. John C. Hall and Brian J. Hall have assembled world leaders on this ever-changing topic of Cutaneous Lymphoma and to explore the advancements in research. The text first discusses the new classifications of cutaneous lymphoma.
Hall, John C.
core  

Cutaneous lymphoma of the tarsus in a cat - Case study

open access: yes, 2017
Lymphoma is the most common lymphoproliferative disorder in cats. Cutaneous lymphoma, however, is a rare form of extranodal lymphoma. Recently, several cutaneous lymphomas at the tarsal region have been reported in cats.
Oscar Sierra, M. [UNESP]   +9 more
core   +1 more source

Cytology‐First Diagnostic Workflow for Melanoma of Unknown Primary With Molecular Profiling

open access: yesCytopathology, EarlyView.
Cytology‑first diagnostic workflow for melanoma of unknown primary. Fine‑needle aspiration of an enlarged lymph node enables rapid cytologic evaluation and immunocytochemical confirmation of melanocytic lineage (SOX10). This early cytologic diagnosis facilitates timely surgical excision and comprehensive genomic profiling, supporting integrated ...
Hong Yu   +3 more
wiley   +1 more source

Primary cutaneous lymphoma in a patient with mastocytosis: Is there an association? [PDF]

open access: yesJAAD Case Rep, 2023
Kincaid CM   +5 more
europepmc   +1 more source

Current state of medical care for patients with mycosis fungoides and Sézary syndrome at a German university hospital – a cross‐sectional study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Studies on the state of medical care for patients with cutaneous T‐cell lymphoma (CTCL) are limited. To date, only secondary data analyses are available for Germany. Patients and Methods Cross‐sectional study conducted over a one‐year recruitment period (01 March 2024 to 28 February 2025) in the dermatological department of a German ...
Inga Hansen‐Abeck   +5 more
wiley   +1 more source

Cutaneous Lymphoma and Antibody-Directed Therapies. [PDF]

open access: yesAntibodies (Basel), 2023
Sernicola A   +3 more
europepmc   +1 more source

Quick assessment of quality‐of‐life in itch: An exploratory validation of the 5‐item pruritus life quality

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Chronic pruritus (CP) significantly impairs quality of life (QoL), but existing patient‐reported QoL tools are either not specific for CP or are very extensive. Patients and methods The 5‐item pruritus life quality (5PLQ, range: 5–25, 7‐day recall) was developed to assess key itch‐related QoL domains (sensory symptoms,
Claudia Zeidler   +14 more
wiley   +1 more source

The different face of skin‐rash induced by brentuximab vedotin

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri   +11 more
wiley   +1 more source

hMZF-2, the Elusive Transcription Factor

open access: yesFrontiers in Genetics, 2020
Alain Chebly   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy